Detalhe da pesquisa
1.
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
Mult Scler
; 30(6): 707-713, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456445
2.
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization.
Mult Scler
; 24(13): 1696-1705, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28911257
3.
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
Neurol Sci
; 37(2): 315-22, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26439919
4.
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
Mult Scler Relat Disord
; 57: 103345, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158454
5.
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.
Neurol Ther
; 11(3): 1193-1208, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653061
6.
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study.
J Clin Med
; 11(8)2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35456175
7.
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.
Pharmaceuticals (Basel)
; 13(12)2020 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33333889
8.
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study.
J Neurol
; 269(5): 2824-2825, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344079